Next Article in Journal
Facilitations and Hurdles of Genetic Testing in Neuromuscular Disorders
Previous Article in Journal
Feasibility, Reproducibility and Validation of Right Ventricular Volume and Function Assessment Using Three-Dimensional Echocardiography
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Nucleic Acid-Based Lateral Flow Biosensor for Salmonella Typhi and Salmonella Paratyphi: A Detection in Stool Samples of Suspected Carriers

by
Zulkiply Nor Amalina
,
Muhammad Fazli Khalid
,
Sjafri Faizul Rahman
,
Muhamad Nuramin Ahmad
,
Mohamad Ahmad Najib
,
Asma Ismail
and
Ismail Aziah
*
Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, Kubang Kerian 16150, Kelantan, Malaysia
*
Author to whom correspondence should be addressed.
Diagnostics 2021, 11(4), 700; https://doi.org/10.3390/diagnostics11040700
Submission received: 25 March 2021 / Revised: 11 April 2021 / Accepted: 11 April 2021 / Published: 14 April 2021
(This article belongs to the Section Diagnostic Microbiology and Infectious Disease)

Abstract

:
A multiplex rapid detection system, based on a PCR-lateral flow biosensor (mPCR-LFB) was developed to identify Salmonella Typhi and Salmonella Paratyphi A from suspected carriers. The lower detection limit for S. Typhi and S. Paratyphi A was 0.16 and 0.08 ng DNA equivalent to 10 and 102 CFU/mL, respectively. Lateral flow biosensor was used for visual detection of mPCR amplicons (stgA, SPAint, ompC, internal amplification control) by labeling forward primers with fluorescein-isothiocyanate (FITC), Texas Red, dinitrophenol (DNP) and digoxigenin (DIG) and reverse primers with biotin. Binding of streptavidin-colloidal gold conjugate with the amplicons resulted in formation of a red color dots on the strip after 15–20 min of sample exposure. The nucleic acid lateral flow analysis of the mPCR-LFB was better in sensitivity and more rapid than the conventional agarose gel electrophoresis. Moreover, the mPCR-LFB showed 100% sensitivity and specificity when evaluated with stools spiked with 100 isolates of Salmonella genus and other bacteria. A prospective cohort study on stool samples of 1176 food handlers in outbreak areas (suspected carriers) resulted in 23 (2%) positive for S. Typhi. The developed assay has potential to be used for rapid detection of typhoid carriers in surveillance program.

1. Introduction

Enteric fever is a public health problem in many developing and underdeveloped countries. However, typhoid fever has become relatively rare in developed countries [1]. The majority of cases are caused by Salmonella Typhi, followed by Salmonella Paratyphi A. The disease is transmitted via consumption of food and water contaminated by individuals who are carriers of the bacteria [2]. According to the World Health Organization (WHO), a carrier is defined as a person who has fully recovered but continues the fecal excretion of S. Typhi intermittently for up to a year thereafter [3]. Approximately 1 to 5% of typhoid patients have been confirmed to be carriers when their stools were tested one-year post-infection [3]. They showed no clinical symptoms but have the potential to cause outbreaks in communities.
Stool culture is the gold standard for diagnosis of typhoid and paratyphoid carriers. However, it takes two to seven days to produce results and requires skilled laboratory personnel to identify the correct bacterial colonies on the selective agar plate [4,5,6,7]. Carriers can also be identified using serological methods such as Vi-ELISA, with a sensitivity and specificity of 95%, compared to 86% by the stool culture method [8]. However, Vi-ELISA is prone to produce false-positive results due to the widespread use of Vi-vaccine which leads to an increase in anti-Vi antibody level [9]. Furthermore, the Vi-ELISA is not commercially available.
Polymerase chain reaction PCR technique has been known to be sensitive, specific, and able to detect multiple pathogens in a single reaction tube [5,10]. Typhoid detection by PCR works by amplifying identified region(s) of the bacterial DNA in blood samples of suspected typhoid patients. Several studies on development and utilization of PCR for typhoid detection concentrated more on detecting S. Typhi in blood in symptomatic patients [4,11,12,13,14,15,16]. PCR amplicons are commonly detected and visualized using conventional agarose gel electrophoresis and an ultraviolet (UV) transilluminator, but this method is time consuming and laborious and requires special equipment and skilled personnel. PCR is also reported to be an effective method to amplify the bacterial genes in stool samples [17,18].
Another method is real-time PCR, and the turnaround time of real-time PCR was often reported to be shorter compared to conventional PCR. A real-time PCR study using cytolysin A (clyA) gene to detect typhoidal and paratyphoidal Salmonella in blood samples showed a sensitivity of 40%, which was similar with blood culture although both methods revealed high specificity of more than 95% [19]. Another experiment using flagellin C (fliC-d) gene showed sensitivity of 91.4% and specificity of 100% [20]. Real-time PCR had been previously used to detect of typhoidal Salmonella, non-typhoidal Salmonella and other enteric pathogens in stool samples of gastrointestinal patients with high sensitivity and specificity of more than 95% [21,22,23]. However, real-time PCR has the limitation that the available master mix reagents and consumables are provided according to the real-time PCR system.
In terms of lateral flow assay development for diagnostics application, several studies were conducted for antibody detection for screening of typhoid and paratyphoid fever [24,25]. A very sensitive confirmatory test is via PCR. PCR has the advantage of adopting lateral flow assay for visualization for amplicons instead of agarose gel electrophoresis. Therefore, an alternative method for laboratory diagnosis of typhoidal and paratyphoidal Salmonella is by performing conventional PCR followed by detection by a lateral flow biosensor (LFB) device; this has comparable turnaround time as real-time PCR since the detection for lateral flow is done in 15–20 min [26]. LFB involves the immobilization of antibody on a solid surface, hybridization of labeled-PCR amplicons and detection by nanoparticles such as colloidal gold [27,28,29,30,31,32]. The detection method is rapid, user-friendly and the results can be observed by naked eye [29,32,33,34,35,36].
The present study describes a multiplex PCR-lateral flow biosensor (mPCR-LFB) for the detection of S. Typhi and S. Paratyphi A using labeled primers. The LFB strip utilized five dots which targeted PCR amplicons of S. Typhi, S. Paratyphi A, pan-Salmonella; an internal amplification control (IAC) and anti-biotin antibody as test control. The analytical sensitivity of the mPCR-LFB was determined at DNA and bacterial levels. Evaluation of this assay was performed on stool samples spiked with S. Typhi, S. Paratyphi A, other Salmonella serovars and other gram-negative bacteria; as well as on stool samples collected from food handlers during outbreaks in Kelantan, Malaysia.

2. Materials and Methods

2.1. Reagents and Apparatus

Goat anti-mouse IgG (whole molecule)-biotin and mouse monoclonal anti-FITC were purchased from Sigma Aldrich (St. Louis, MO, USA); anti-digoxigenin was from Roche (Penzberg, Germany); anti-Texas red and anti-dinitrophenyl-KLH were from Invitrogen (Carlsbad, CA, USA), and streptavidin-colloidal gold conjugate (40 nm) was from Kestrel BioSciences (Carlsbad, CA, USA). Other materials used in this study were plastic adhesive backing card from G&L Precision Die-cutting (Amstelveen, Netherlands), Unisart CN95 nitrocellulose membrane from Sartorius (Goettingen, Germany), C048 absorbent pad from Millipore (Burlington, MA, USA), No. 8964 conjugate pad from Ahlostrom (Helsinki, Finland), and No. 319 sample pads from Ahlstrom (Helsinki, Finland). Agarose, deoxynucleotide triphosphates (dNTPs), Taq DNA polymerase and a 25 bp DNA ladder were purchased from Promega (Madison, WI, USA).
All primers used in this study were designed using Primer Explorer V4 software, targeting the specific regions of Salmonella Typhi genome retrieved from the GenBank (Table 1). The labeled primers were synthesized by Bioneer Corporation (Daejeon, Korea). The running buffer for the lateral flow biosensor contained 1% bovine serum albumin (BSA) and 0.05% Tween-20 in phosphate buffered saline, pH 7.4 (PBS). The assembled lateral flow biosensor was cut into strips using an automatic strip cutter (Kinematic Automation, Sonora, CA, USA). PCR amplification reactions were performed in a PTC-200 MJ Research Thermal Cycler (Ramsey, MN, USA), and amplicons were analyzed using a Syngene UV transilluminator (Cambridge, UK).

2.2. Collection of Bacterial Strains and Stool Samples

A total of 100 bacterial isolates, including 25 S. Typhi, 25 S. Paratyphi A, 25 other Salmonella serovars, and 25 non-Salmonella, were stock cultures kept at the Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia. A total of 1176 stool samples from food handlers and suspected carriers collected from the Kelantan Public Health Laboratory Kota Bharu, Kelantan, were used in the test evaluation. All samples were obtained with informed consent from food handlers and suspected carriers, and ethical clearance was obtained from the Human Ethics Committee, Universiti Sains Malaysia (USMKK/PPP/JEPeM [226.4.(1.9)]) dated 2 June 2010.

2.3. Preparation and Extraction of DNA from Stool Samples

Spiked stool samples were prepared by adding 1 g of stool sample and 1 mL of bacterial culture to a final volume of 20 mL in Selenite F broth. Serial dilutions of bacterial cultures were used to determine the analytical sensitivity. A total of one gram of stool sample was collected from each food handler and suspected carrier and cultured in a final volume of 20 mL in Selenite F broth for the enrichment and selection. The samples were further incubated at 37 °C for 24 h. Then, 1 mL of bacterial culture from the upper layer of Selenite F broth was transferred into a new 1.5 mL tube. The DNA was extracted using the boiling method [11].

2.4. Multiplex PCR Assay

A multiplex PCR assay for S. Typhi and S. Paratyphi A in the presence of Salmonella genus and a non-competitive internal amplification control (IAC) was carried out in a final volume of 20 μL. The reaction mixture contained 1X colorless GoTaq Flexi buffer; 200 μmol/L dNTPs mix; 3 mM MgCl2; 0.5 μM FITC_stgAF and Biotin_stgAR primers; 0.5 μM Texas red_SPAintF and Biotin_SPAintR primers; 0.3 μM DNP_ompCF and Biotin_ompCR primers; 0.7 μM DIG_HemMP and Biotin_18R-1 primers; 1.5 U of GoTaq DNA Polymerase; and 40 pg of an IAC plasmid containing the hemM gene.
PCR was performed using 1 μL of extracted DNA sample in a thermal cycler with the following cycling parameters: 94 °C for 5 min, followed by 25 cycles of denaturation at 94 °C for 30 s, annealing at 61 °C for 1 min 30 s, and elongation at 72 °C for 1 min, with a final extension at 72 °C for 7 min.
A positive control (containing 10 ng of a DNA template of S. Typhi, S. Paratyphi A and the IAC) and a negative control (containing only a DNA template of the IAC) were included in the mPCR assay. The amplification products were detected by two methods: (i) 3% agarose gel electrophoresis in the presence of 0.5 μg/mL ethidium bromide visualized under UV transilluminator and photographed using an image analyzer and (ii) a lateral flow biosensor.

2.5. Preparation of the Lateral-Flow Biosensor Strip

The lateral flow biosensor strip (5 mm × 73 mm) was assembled by placing a sample pad, conjugate pad, nitrocellulose membrane and absorbent pad on a plastic adhesive backing card to provide a solid support for the strip. The streptavidin-colloidal gold conjugate was placed onto the conjugate pad in the presence of trehalose as a stabilizer. The assembled pads were cut into strips of 5 mm width using an automatic strip cutter. Five capture reagents were dotted onto the nitrocellulose membrane: (i) anti-mouse IgG-biotin antibody (biotin) as control; (ii) mouse monoclonal anti-FITC (anti-FITC) as the S. Typhi target; (iii) monoclonal anti-Texas red as the S. Paratyphi A target; (iv) anti-dinitrophenyl-KLH, rabbit IgG fraction (anti-DNP) as the pan-Salmonella target; and (v) anti-digoxigenin (anti-DIG) as the IAC target. The schematic diagram is shown in Figure 1.

2.6. Visual Detection of PCR Amplicons Using the Lateral Flow Biosensor

After PCR amplification, 10 μL PCR product and 150 μL running buffer were added to the sample pad of the biosensor strip. The mixture migrated towards the absorbent pad by capillary action. After 15 min, the result was read based on the presence of red dots on the LFB strip. The presence of five red dots on the positive control strip (strip control, S. Typhi, S. Paratyphi A, Salmonella genus and IAC) and two target dots (strip control and IAC targets) on the negative control strip indicate that the reaction was valid.

2.7. Validation of the Primers for the mPCR-LFB

The performance of the primers was validated by calculating the sensitivity and specificity of the mPCR-LFB using genomic DNA extracted from 100 bacterial isolates, including 25 S. Typhi, 25 S. Paratyphi A, 25 other Salmonella serovars and 25 non-Salmonella serovars.

2.8. Determination of Analytical Sensitivity and Validation of the mPCR-LFB

The analytical sensitivity of the mPCR-LFB was determined at the DNA level using genomic DNA extracted from American Type Culture Collection (ATCC) strains of S. Typhi (ATCC 7251) and S. Paratyphi A (ATCC 9150). Bacterial counts were also performed to determine CFU/mL. The genomic DNA was serially diluted (two-fold dilutions) with 10 mM Tris-HCl, pH 8.0, at concentrations ranging from 10 ng to 0.02 ng prior to multiplex PCR. The limit of detection (LoD) of the mPCR-LFB was also validated using DNA extracted from stool samples spiked with serially diluted S. Typhi and S. Paratyphi A culture (107 to 101 CFU/mL). The analytical sensitivity and the LoD for the mPCR-LFB were compared with mPCR-agarose gel electrophoresis (mPCR-AGE). The sensitivity and specificity of the mPCR-LFB were validated using DNA extracted from 100 stool samples spiked with 107 CFU/mL bacterial isolates, including 25 S. Typhi, 25 S. Paratyphi A, 25 other Salmonella serovars and 25 non-Salmonella serovars.

2.9. Detection of Carriers among Food Handlers Using the mPCR-LFB and Culture Method

The mPCR-LFB was tested with 1176 stool samples of food handlers without history of typhoid and suspected carriers with a history of typhoid. PCR amplicons were detected by both AGE and LFB, and their data were compared. The five capture reagents were immobilized onto the nitrocellulose membrane, and the final format of test is in line-format. The culture method followed by biochemical test was also performed for each sample according to the standard microbiological techniques.

3. Results

3.1. mPCR-LFB

The biosensor was designed to detect double-stranded DNA sequences that were labeled at both 5′-ends of each strand, one of the labels being biotin and another comprising a dye or DIG. The dyes were (i) FITC for stgA gene of S. Typhi, (ii) Texas red for intergenic region of SSPA1723a and SSPA1724 of S. Paratyphi A, and (iii) DNP for ompC gene of pan-Salmonella. The latter was included as a control, whereby any amplification of S. Typhi/S. Paratyphi A must be accompanied by amplification of ompC gene. The DIG was used as capture of IAC amplicon, and its absence indicates false negative results due to incorrect PCR mixture, thermal cycler malfunction, or presence of inhibitors [37]. The amplified PCR products for S. Typhi (70 bp), S. Paratyphi A (93 bp), Salmonella genus (146 bp), and IAC (123 bp) were observed on agarose gel.

3.2. Validation of the Primers for the mPCR-LFB

The mPCR-LFB was tested with genomic DNA extracted from 100 isolates of Salmonella serovars, including S. Typhi and S. Paratyphi A, and non-Salmonella isolates. All amplicons were detected by both the lateral flow biosensor and agarose gel electrophoresis. The results showed that both the mPCR-LFB and mPCR-AGE were 100% sensitive and specific (Table 2).

3.3. Comparison of the Analytical Sensitivity of the mPCR-LFB and mPCR-AGE

The analytical sensitivities at the DNA level for S. Typhi and S. Paratyphi A by mPCR-LFB were 0.16 ng and 0.08 ng, respectively, whereas mPCR-AGE showed that both serovars can be detected as low as 0.63 ng (Figure 2).

3.4. Limit of Detection and Evaluation of the mPCR-LFB Using Spiked Stool Samples

The limit of detection (LoD) of the mPCR-LFB at the bacterial level was determined using stool samples spiked with S. Typhi and S. Paratyphi A. It was found to be 101 CFU/mL for S. Typhi and 102 CFU/mL for S. Paratyphi A, while the detection limit of mPCR-AGE was 104 CFU/mL for both S. Typhi and S. Paratyphi A (Figure 3).
Evaluation mPCR-LFB was performed using stool samples spiked with 100 bacterial isolates, including 25 S. Typhi, 25 S. Paratyphi A, 25 other Salmonella serovars and 25 non-Salmonella serovars, and the result showed 100% sensitivity and specificity. The mPCR-LFB results were also fully consistent with those of mPCR-AGE.

3.5. Performance of Carriers’ Detection among Food Handlers Using the mPCR-LFB Compared to Culture Method

The mPCR-LFB was applied to detect S. Typhi and S. Paratyphi A using DNA extracted from 1176 stool samples of food handlers besides the routine culture method. The representative of the mPCR-LFB in line-format is shown in Figure 4. The method was able to detect S. Typhi in 23 (2.0%) samples and S. Paratyphi A in 3 (0.3%) samples while the culture method detected S. Typhi and S. Paratyphi A in only 3 (0.3%) and 1 (0.1%) sample, respectively (Table 3). There was no PCR inhibitor detected in all samples.

4. Discussion

In this study, PCR-lateral flow biosensor was developed in which PCR product was applied on the sample pad of a lateral flow strip together with running buffer. The mixture rehydrated and released the adjacent dried streptavidin-colloidal gold conjugate, followed by binding to the 5′-biotin labeled amplicons. The complex then moved up the membrane strip by capillary action. The PCR amplicons that were labeled with 5′-FITC, 5′-Texas red, 5′-DNP or 5′-DIG then bound with their respective capture reagents immobilized on the membrane. The accumulation of streptavidin-colloidal gold conjugate at the respective areas was visualized as a red dot for test, while conjugation bound with biotin at the control zone indicated the proper functioning of the lateral flow biosensor [32,38].
Colloidal gold nanoparticles were used in this lateral flow biosensor due to its high affinity and ease to be functionalized on biomolecules. The advantages of gold nanoparticles include good stability, high affinity towards biomolecules, environmentally friendly, and having an intense red color that can be easily detected by the naked eye or by a reader [38,39,40,41,42,43]. The mPCR-LFB detected and indirectly visualized the amplified product of S. Typhi or S. Paratyphi A by formation of red dots after 15 min of amplicons application onto the lateral flow strip. The biosensor was designed to allow both primers to be labeled instead of using a labeled probe, thus eliminating the need for the DNA strands to be denatured and single stranded DNA hybridized to the labeled probe.
The diagnosis of a chronic carrier using culture of stool sample and confirmation by biochemical test and serology is time consuming as it needs 2–7 days to produce results. Application of PCR after sample enrichment reduces the time taken, and the more recent introduction of lateral flow assay as an alternative to agarose gel electrophoresis further reduces the turnaround time from four hours to two hours [23].
The primers derived from the genes revealed that the primers were highly specific since the test did not cross-react with other bacteria; thus, the assay has potential to be used as a confirmatory test for detection of S. Typhi and S. Paratyphi A from suspected typhoid carriers. Validation or evaluation with clinical isolates is necessary for prototype development as supported by previous studies that also incorporated S. Typhi, S. Paratyphi A, other Salmonella spp. and other related bacteria to ensure the higher level of sensitivity and specificity before testing with clinical samples [20,44,45].
Detection by the lateral flow biosensor was 4- and 6-fold more sensitive compared to conventional agarose gel electrophoresis for detection of S. Typhi and S. Paratyphi A, respectively. In terms of the load of bacteria (CFU/mL) spiked in the stool samples, detection by PCR-LFB was found to be in the range of 10 to 103-fold more sensitive compared to PCR-AGE. Therefore, detection of PCR amplicons by lateral flow biosensor proved to be more sensitive than agarose gel electrophoresis. The results are supported by previous studies on other diseases, which showed that the lateral flow biosensor was more sensitive than agarose gel electrophoresis [34,46,47].
The sensitivity and specificity of mPCR-LFB in this study revealed high sensitivity and specificity of 100% when tested with spiked stool samples. Furthermore, the performance of the mPCR-LFB in prospective study in stool samples of food handlers showed a higher percentage of positivity by mPCR-LFB compared to culture method. Higher percentage of positivity in mPCR-LFB compared to culture method (S Typhi: 2.0% vs. 0.3%; S. Paratyphi A: 0.3% vs. 0.1%) suggests that the test has potential to be used as an alternative tool for detecting the typhoid carriers from stool samples of asymptomatic food handlers or suspected carriers in typhoid outbreak hotspots.
Similar studies had been conducted and have also shown the successful development of nucleic acid-based assays for detection of Salmonella spp. and other gastrointestinal bacteria in poultry products and stools of suspected gastrointestinal patients [21,22,48]. The studies demonstrated molecular methods are highly sensitive and specific by utilizing multiplex PCR-agarose gel and multiplex real-time PCR for the detection of the bacteria compared to gold standard culture method which is used as routine microbiological method for isolation and identification of the bacteria in clinical samples. The studies showed sensitivity and specificity of more than 95% suggesting the high accuracy of the developed assays. The above-mentioned studies focused on the nucleic acid assays for non-typhoidal Salmonella and other gastrointestinal bacteria whereas this mPCR-LFB focused on the detection of typhoid carriers.
The other study had utilized multiplex real-time PCR to detect S. Typhi and S. Paratyphi in stool samples [22] with the analytical sensitivity of 103 CFU/mL for both bacteria. This mPCR-LFB has showed better performance with a sensitivity of 10 and 102 CFU/mL for S. Typhi and S. Paratyphi, respectively. In addition to that mPCR-LFB also offers benefit over multiplex real-time PCR as require cheaper cost of equipment and lower technical skilled lab technicians to operate and interpret the results.
The finding of this study suggested that mPCR-LFB has the potential to be used as a diagnostic tool for carrier detection. Furthermore, this assay is simple, rapid, highly sensitive, and specific and does not require any tedious procedure or sophisticated equipment.

5. Conclusions

The mPCR-LFB developed in this study was able to fulfill most of WHO criteria of a diagnostic test suitable for low resource settings, i.e., rapid, robust, sensitive, specific, and user-friendly. It showed good potential for detecting carriers among food handlers and suspected carriers and thus merits further validation studies.

Author Contributions

Conceptualization, A.I. and I.A.; methodology, Z.N.A., M.F.K., S.F.R., M.N.A., and I.A.; software, Z.N.A.; validation, Z.N.A., M.F.K., M.A.N. and I.A.; formal analysis, Z.N.A., S.F.R., M.N.A., and I.A.; investigation, Z.N.A., M.F.K., S.F.R., and M.N.A.; resources, A.I. and I.A.; data curation, Z.N.A., M.F.K., and I.A.; writing—original draft preparation, Z.N.A., writing—review and editing, M.F.K., M.A.N., and I.A.; visualization, Z.N.A., S.F.R., and M.N.A.; supervision, A.I. and I.A.; project administration, Z.N.A., M.F.K., S.F.R., M.N.A., A.I., and I.A.; funding acquisition, A.I. and I.A. All authors have read and agreed to the published version of the manuscript.

Funding

This study was funded by Short Term Grant (304/CIPPM/61310046), Research University Cluster Grant (1001/PSKBP/8630016) and Dana Inovasi Awal Grant (1001/CIPPM/AUPI00256) from Universiti Sains Malaysia and Higher Institution Centre of Excellence (HICoE) Grant (311/CIPPM/4401005) from Ministry of Higher Education, Malaysia.

Institutional Review Board Statement

The study was conducted according to the guidelines of the International Council for Harmonisation (ICH) Good Clinical Practice (GCP) and approved by the Ethics Committee of Universiti Sains Malaysia (USMKK/PPP/JEPeM [226.4.(1.9)] and dated 2 June 2010).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Acknowledgments

The authors would like to thank the INFORMM typhoid team for help in culturing the bacteria. The first and third authors were financially supported by fellowships from the Institute of Postgraduate Studies, USM.

Conflicts of Interest

The authors have declared that no competing interests exist.

References

  1. Procaccianti, M.; Motta, A.; Giordani, S.; Riscassi, S.; Guidi, B.; Ruffini, M.; Maffini, V.; Esposito, S.; Dodi, I. First Case of Typhoid Fever due to Extensively Drug-resistant Salmonella enterica serovar Typhi in Italy. Pathogens 2020, 9, 151. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Chua, A.L.; Aziah, I.; Balaram, P.; Bhuvanendran, S.; Anthony, A.A.; Mohmad, S.N.; Nasir, N.M.; Hassan, H.; Naim, R.; Meran, L.P.; et al. Identification of carriers among individuals recruited in the typhoid registry in Malaysia using stool culture, polymerase chain reaction, and dot enzyme immunoassay as detection tools. Asia Pac. J. Public Health 2012, 27, NP2740–NP2748. [Google Scholar] [CrossRef] [PubMed]
  3. WHO. Background Document: The Diagnosis, Treatment and Prevention of Typhoid Fever. Communicable Disease Surveillance and Response Vaccines and Biologicals; Retrieved from WHO/V&B/03.07; WHO: Geneva, Switzerland, 2013; pp. 1–33. [Google Scholar]
  4. Zhou, L.; Pollard, A.J. A fast and highly sensitive blood culture PCR method for clinical detection of Salmonella enterica serovar Typhi. Ann. Clin. Microbiol. Antimicrob. 2010, 9, 14. [Google Scholar] [CrossRef] [Green Version]
  5. Hatta, M.; Smits, H.L. Detection of Salmonella Typhi by nested polymerase chain reaction in blood, urine and stool samples. Am. J. Trop. Med. Hyg. 2007, 76, 139–143. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Kumar, S.; Balakrishna, K.; Singh, G.P.; Batra, H.V. Rapid detection of Salmonella typhi in foods by combination of immunomagnetic separation and polymerase chain reaction. World J. Microbiol. Biotechnol. 2005, 21, 625–628. [Google Scholar] [CrossRef]
  7. Osek, J. Rapid and specific identification of Shiga toxin-producing Escherichia coli in faeces by multiplex PCR. Lett. Appl. Microbiol. 2002, 34, 304–310. [Google Scholar] [CrossRef] [Green Version]
  8. Losonsky, G.A.; Ferreccio, C.; Kotloff, K.L.; Kaintuck, S.; Robbins, J.B.; Levine, M.M. Development and evaluation of an enzyme-linked immunosorbent assay for serum Vi antibodies for detection of chronic Salmonella typhi carriers. J. Clin. Microbiol. 1987, 25, 2266–2269. [Google Scholar] [CrossRef] [Green Version]
  9. Gupta, A.; My Thanh, N.T.; Olsen, S.J.; Sivapalasingam, S.; My Trinh, T.T.; Phuong Lan, N.T.; Hoekstra, R.M.; Bibb, W.; Minh, N.T. Evaluation of community-based serologic screening for identification of chronic Salmonella Typhi carriers in Vietnam. Int. J. Infect. Dis. 2006, 10, 309–314. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  10. Yager, P.; Domingo, G.J.; Gerdes, J. Point-of-care diagnostics for global health. Annu Rev. Biomed. Eng. 2008, 10, 107–144. [Google Scholar] [CrossRef]
  11. Aziah, I.; Ravichandran, M.; Ismail, A. Amplification of ST50 gene using dry-reagent-based polymerase chain reaction for the detection of Salmonella typhi. Diagn Microbiol. Infect. Dis. 2007, 59, 373–377. [Google Scholar] [CrossRef] [PubMed]
  12. Banavandi, M.J.S.; Hasan, S.; Shahbazzadeh, D.; Mirzahosseini, H.; Mahboudi, F.; Abachi, M.; Karimi, V.; Gh, R.J. Selective amplification of prt, tyV and invA genes by multiplex PCR. Iran. Biomed. J. 2005, 9, 135–138. [Google Scholar]
  13. Hirose, K.; Itoh, K.; Nakajima, H.; Kurazono, T.; Yamaguchi, M.; Moriya, K.; Ezaki, T.; Kawamura, Y.; Tamura, K.; Watanabe, H. Selective amplification of tyv (rfbE). prt (rfbS), viaB, and fliC genes by multiplex PCR for identification of Salmonella enterica serovars Typhi and Paratyphi A. J. Clin. Microbiol. 2002, 40, 633–636. [Google Scholar] [CrossRef]
  14. Levy, H.; Diallo, S.; Tennant, S.M.; Livio, S.; Sow, S.O.; Tapia, M.; Fields, P.I.; Mikoleit, M.; Tamboura, B.; Kotloff, K.L. PCR method to identify Salmonella enterica serovars Typhi, Paratyphi A, and Paratyphi B among Salmonella isolates from the blood of patients with clinical enteric fever. J. Clin. Microbiol. 2008, 46, 1861–1866. [Google Scholar] [CrossRef] [Green Version]
  15. Pouzol, S.; Tanmoy, A.M.; Ahmed, D.; Khanam, F.; Brooks, W.A.; Bhuyan, G.S.; Fabre, L.; Bryant, J.E.; Gustin, M.P.; Vanhems, P.; et al. Clinical evaluation of a multiplex PCR for the detection of Salmonella enterica serovars Typhi and Paratyphi A from blood specimens in a high-endemic setting. Am. J. Trop. Med. Hyg. 2019, 101, 513–520. [Google Scholar] [CrossRef] [PubMed]
  16. Song, J.H.; Cho, H.; Park, M.Y.; Na, D.S.; Moon, H.B.; Pai, C.H. Detection of Salmonella typhi in the blood of patients with typhoid fever by polymerase chain reaction. J. Clin. Microbiol. 1993, 31, 1439–1443. [Google Scholar] [CrossRef] [Green Version]
  17. Ngan, G.J.Y.; Ng, L.M.; Lin, R.T.P.; Teo, J.W.P. Development of a novel multiplex PCR for the detection and differentiation of Salmonella enterica serovars Typhi and Paratyphi A. Res. Microbiol. 2010, 161, 243–248. [Google Scholar] [CrossRef] [PubMed]
  18. Teh, C.S.J.; Chua, K.H.; Puthucheary, S.D.; Thong, K.L. Further evaluation of a multiplex PCR for differentiation of Salmonella paratyphi A from other Salmonellae. Jpn. J. Infect. Dis. 2008, 61, 313–314. [Google Scholar] [PubMed]
  19. Tennant, S.M.; Toema, D.; Qamar, F.; Iqbal, N.; Boyd, M.A.; Marshall, J.M.; Blackwelder, W.C.; Wu, Y.; Quadri, F.; Khan, A.; et al. Detection of Typhoidal and Paratyphoidal Salmonella in blood by Real-time Polymerase Chain Reaction. Clin. Infect. Dis. 2015, 61, 241–250. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  20. Das, S.; Ray, U.; Akhter, I.; Chattopadhyay, A.; Paul, D.K.; Dutta, S. Evaluation of fliC-d based direct blood PCR assays for typhoid diagnosis. BMC Microbiol. 2016, 16, 108. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  21. Martín, A.; Pérez-Ayala, A.; Chaves, F.; Lora, D.; Orellana, M.Á. Evaluation of the multiplex PCR Allplex-GI assay in the detection of bacterial pathogens in diarrheic stool samples. J. Microbiol. Methods 2018, 144, 33–36. [Google Scholar] [CrossRef] [PubMed]
  22. Teh, C.S.J.; Lau, M.Y.; Chong, C.W.; Ngoi, S.T.; Chua, K.H.; Lee, W.S.; Thong, K.L. One-step differential detection of Salmonella enterica serovar Typhi, serovar Paratyphi A and other Salmonella spp. by using a quadruplex real-time PCR assay. J. Microbiol. Methods 2021, 183, 106184. [Google Scholar] [CrossRef]
  23. Valledor, S.; Valledor, I.; Gil-Rodríguez, M.C.; Seral, C.; Castillo, J. Comparison of several real-time PCR kits versus a culture-dependent algorithm to identify enteropathogens in stool samples. Sci. Rep. 2020, 10, 4301. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Khan, I.H.; Sayeed, M.A.; Sultana, N.; Islam, K.; Amin, J.; Faruk, M.O.; Khan, U.; Khanam, F.; Ryan, E.T.; Qadri, F. Development of a simple, peripheral-blood-based lateral-flow dipstick assay for accurate detection of patients with enteric fever. Clin. Vaccine Immunol. 2016, 23, 403–409. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Kumar, S.; Nodoushani, A.; Khanam, F.; DeCruz, A.T.; Lambotte, P.; Scott, R.; Bogoch, I.I.; Vaidya, K.; Calderwood, S.B.; Bhuiyan, T.R.; et al. Evaluation of a Rapid Point-of-Care Multiplex Immunochromatographic Assay for the Diagnosis of Enteric Fever. Msphere 2020, 5, e00253-20. [Google Scholar] [CrossRef] [PubMed]
  26. Anfossi, L.; Di Nardo, F.; Cavalera, S.; Giovannoli, C.; Baggiani, C. Multiplex Lateral Flow Immunoassay: An Overview of Strategies towards High-throughput Point-of-Need Testing. Biosensors 2018, 9, 2. [Google Scholar] [CrossRef] [Green Version]
  27. Akinwale, O.P.; Laurent, T.; Mertens, P.; Leclipteux, T.; Rollinson, D.; Kane, R.; Emery, A.; Ajayi, M.B.; Akande, D.O.; Fesobi, T.W. Detection of schistosomes polymerase chain reaction amplified DNA by oligochromatographic dipstick. Mol. Biochem Parasitol. 2008, 160, 167–170. [Google Scholar] [CrossRef]
  28. Blazkova, M.; Koets, M.; Wichers, J.H.; van Amerongen, A.; Fukal, L.; Rauch, P. Nucleic acid lateral flow immunoassay for the detection of pathogenic bacteria from food. Czech. J. Food Sci. 2009, 27, 350–353. [Google Scholar] [CrossRef]
  29. Deborggraeve, S.; Coronado, X.; Solari, A.; Zulantay, I.; Apt, W.; Mertens, P.; Laurent, T.; Leclipteux, T.; Stessens, T.; Dujardin, J.C.; et al. cruzi OligoC-TesT: A simplified and standardized polymerase chain reaction format for diagnosis of Chagas disease. PLoS Negl Trop Dis. 2009, 3, e450. [Google Scholar] [CrossRef] [Green Version]
  30. Mens, P.F.; Amerongen, A.V.; Sawa, P.; Kager, P.A.; Schallig, H.D.F.H. Molecular diagnosis of malaria for the field: Development of a novel, 1-step nucleic acid lateral flow immunoassay for the detection of all 4 human Plasmodium spp. and its evaluation Mbita, Kenya. Diagn Microbiol. Infect. Dis. 2008, 61, 421–427. [Google Scholar] [CrossRef] [PubMed]
  31. Hsieh, H.V.; Dantzler, J.L.; Weigl, B.H. Analytical Tools to Improve Optimization Procedures for Lateral Flow Assays. Diagnostics 2017, 7, 29. [Google Scholar] [CrossRef] [Green Version]
  32. Zhan, L.; Guo, S.Z.; Song, F.; Gong, Y.; Xu, F.; Boulware, D.R.; McAlpine, M.C.; Chan, W.C.W.; Bischof, J.C. The Role of Nanoparticle Design in Determining Analytical Performance of Lateral Flow Immunoassays. Nano Lett. 2017, 17, 7207–7212. [Google Scholar] [CrossRef] [Green Version]
  33. Mugasa, C.M.; Laurent, T.; Schoone, G.J.; Kager, P.A.; Lubega, G.W.; Schallig, H.D. Nucleic Acid Sequence-Based Amplification with Oligochromatography for Detection of Trypanosoma brucei in Clinical Samples. J. Clin. Microbiol. 2009, 47, 630–635. [Google Scholar] [CrossRef] [Green Version]
  34. Ang, G.Y.; Yu, C.Y.; Yean, C.Y. Ambient temperature detection of PCR amplicons with a novel sequence-specific nucleic acid lateral flow biosensor. Biosens. Bioelectron. 2012, 38, 151–156. [Google Scholar] [CrossRef] [PubMed]
  35. Chua, A.; Yean, C.Y.; Ravichandran, M.; Lim, B.; Lalitha, P. A rapid DNA biosensor for the molecular diagnosis of infectious disease. Biosens. Bioelectron. 2011, 26, 3825–3831. [Google Scholar] [CrossRef]
  36. Kalogianni, D.P.; Litos, I.K.; Christopoulos, T.K.; Ioannou, P.C. Dipstick-type biosensor for visual detection of DNA with oligonucleotide-decorated colored polystyrene microspheres as reporters. Biosens. Bioelectron. 2009, 24, 1811–1815. [Google Scholar] [CrossRef] [PubMed]
  37. Hoorfar, J.; Cook, N.; Malorny, B.; Wagner, M.; De Medici, D.; Abdulmawjood, A.; Fach, P. Making internal amplification control mandatory for diagnostic PCR. J. Clin. Microbiol. 2003, 41, 5835. [Google Scholar] [CrossRef] [Green Version]
  38. Zhang, C.; Zhang, Y.; Wang, S. Development of multianalyte flow-through and lateral-flow assays using gold particles and horseradish peroxidase as tracers for the rapid determination of carbaryl and endosulfan in agricultural products. J. Agric. Food Chem. 2006, 54, 2502–2507. [Google Scholar] [CrossRef] [PubMed]
  39. Sajid, M.; Kawde, A.N.; Daud, M. Designs, formats and applications of lateral flow assay: A literature review. J. Saudi Chem. Soc. 2015, 19, 689–705. [Google Scholar] [CrossRef] [Green Version]
  40. Quesada-González, D.; Merkoçi, A. Nanoparticle-based lateral flow biosensors. Biosens. Bioelectron. 2015, 73, 47–63. [Google Scholar] [CrossRef] [Green Version]
  41. Jung, Y.L.; Jung, C.; Parab, H.; Li, T.; Park, H.G. Direct colorimetric diagnosis of pathogen infections by utilizing thiol-labeled PCR primers and unmodified gold nanoparticles. Biosens. Bioelectron. 2010, 25, 1941–1946. [Google Scholar] [CrossRef]
  42. Posthuma-Trumpie, G.A.; Korf, J.; Amerongen, A.V. Lateral flow (immuno)assay: Its strengths, weaknesses, opportunities and threats. A literature survey. Anal. Bioanal. Chem. 2009, 393, 569–582. [Google Scholar] [CrossRef] [Green Version]
  43. Storhoff, J.J.; Lazarides, A.A.; Mucic, R.C.; Mirkin, C.A.; Letsinger, R.L.; Schatz, G.C. What Controls the Optical Properties of DNA-Linked Gold Nanoparticle Assemblies? J. Am. Chem. Soc. 2000, 122, 4640–4650. [Google Scholar] [CrossRef]
  44. Goay, Y.X.; Chin, K.L.; Tan, C.L.; Yeoh, C.Y.; Ja’afar, J.N.; Zaidah, A.R.; Chinni, S.V.; Phua, K.K. Identification of Five Novel Salmonella Typhi-Specific Genes as Markers for Diagnosis of Typhoidal Fever Using Single-Gene Target PCR Assay. Biomed. Res. Int. 2016. [Google Scholar] [CrossRef] [Green Version]
  45. Pratap, C.B.; Kumar, G.; Patel, S.K.; Shukla, V.K.; Kumar, K.; Singh, T.B.; Nath, G. Mix infection of S. typhi and S. paratyphi A in typhoid fever and chronic typhoid carriers: A nested PCR-based study in North India. J. Clin. Diagn Res. 2014, 8, 9–14. [Google Scholar] [CrossRef] [PubMed]
  46. Deborggraeve, S.; Claes, F.; Laurent, T.; Mertens, P.; Leclipteux, T.; Dujardin, J.C.; Herdewijn, P.; Büscher, P. Molecular dipstick test for diagnosis of sleeping sickness. J. Clin. Microbiol. 2006, 44, 2884–2889. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  47. Glynou, K.; Ioannou, P.C.; Christopoulos, T.K.; Syriopoulou, V. Oligonucleotide-functionalized gold nanoparticles as probes in a dry-reagent strip biosensor for DNA analysis by hybridization. Anal. Chem. 2003, 75, 4155–4160. [Google Scholar] [CrossRef] [PubMed]
  48. Park, S.H.; Ricke, S.C. Development of multiplex PCR assay for simultaneous detection of Salmonella genus, Salmonella subspecies I, Salm. Enteritidis, Salm. Heidelberg and Salm. Typhimurium. J. Appl. Microbiol. 2015, 118, 152–160. [Google Scholar] [CrossRef]
Figure 1. Schematic illustration of the principle of the multiplex PCR-lateral flow biosensor (mPCR-LFB) for the visualization of PCR amplicons using immobilized capture reagents on the nitrocellulose membrane. The target PCR amplicon for pan-Salmonella is dinitrophenyl and biotin labeled and is captured on the Salmonella reaction area; S. Paratyphi A is Texas red and biotin labeled and is captured on the S. Paratyphi A reaction area; S. Typhi is FITC and biotin labeled and is captured on the S. Typhi reaction area, and the internal amplification control (IAC) is digoxigenin and biotin labeled and is captured on the IAC reaction area. The accumulation of streptavidin-colloidal gold conjugate in the respective areas produced visible red dots. Excess streptavidin-colloidal gold conjugate is captured on the control reaction area for the validation of the lateral flow biosensor. G = streptavidin-colloidal gold conjugate; B = biotin; DN = dinitrophenyl; ADN = anti-dinitrophenyl; DG = digoxigenin; ADG = anti-digoxigenin; T = Texas red; AT = anti-Texas red; and F = FITC; AF = anti-FITC.
Figure 1. Schematic illustration of the principle of the multiplex PCR-lateral flow biosensor (mPCR-LFB) for the visualization of PCR amplicons using immobilized capture reagents on the nitrocellulose membrane. The target PCR amplicon for pan-Salmonella is dinitrophenyl and biotin labeled and is captured on the Salmonella reaction area; S. Paratyphi A is Texas red and biotin labeled and is captured on the S. Paratyphi A reaction area; S. Typhi is FITC and biotin labeled and is captured on the S. Typhi reaction area, and the internal amplification control (IAC) is digoxigenin and biotin labeled and is captured on the IAC reaction area. The accumulation of streptavidin-colloidal gold conjugate in the respective areas produced visible red dots. Excess streptavidin-colloidal gold conjugate is captured on the control reaction area for the validation of the lateral flow biosensor. G = streptavidin-colloidal gold conjugate; B = biotin; DN = dinitrophenyl; ADN = anti-dinitrophenyl; DG = digoxigenin; ADG = anti-digoxigenin; T = Texas red; AT = anti-Texas red; and F = FITC; AF = anti-FITC.
Diagnostics 11 00700 g001
Figure 2. The analytical sensitivity of the mPCR-LFB and mPCR-AGE was determined using different concentrations of PCR amplicons ranging from 0.02 to 10 ng. (A) The analytical sensitivity using genomic DNA of S. Typhi was 0.63 ng using mPCR-AGE and 0.16 ng using the mPCR-LFB. (B) The analytical sensitivity using genomic DNA of S. Paratyphi A was 0.63 ng using mPCR-AGE and 0.08 ng using the mPCR-LFB. M= 25 bp markers, +ve= positive control, −ve= negative control.
Figure 2. The analytical sensitivity of the mPCR-LFB and mPCR-AGE was determined using different concentrations of PCR amplicons ranging from 0.02 to 10 ng. (A) The analytical sensitivity using genomic DNA of S. Typhi was 0.63 ng using mPCR-AGE and 0.16 ng using the mPCR-LFB. (B) The analytical sensitivity using genomic DNA of S. Paratyphi A was 0.63 ng using mPCR-AGE and 0.08 ng using the mPCR-LFB. M= 25 bp markers, +ve= positive control, −ve= negative control.
Diagnostics 11 00700 g002
Figure 3. Limit of detection (LoD) of the mPCR-LFB and mPCR-AGE were determined using different concentrations of PCR amplicons ranging from 107 to 101 CFU/mL. (A) LoD using DNA of S. Typhi was 104 CFU/mL using mPCR-AGE and 101 CFU/mL using mPCR-LFB. (B) LoD using DNA of S. Paratyphi A was 104 CFU/mL using mPCR-AGE and 102 CFU/mL using mPCR-LFB. M= 25 bp markers, +ve= positive control, -ve= negative control.
Figure 3. Limit of detection (LoD) of the mPCR-LFB and mPCR-AGE were determined using different concentrations of PCR amplicons ranging from 107 to 101 CFU/mL. (A) LoD using DNA of S. Typhi was 104 CFU/mL using mPCR-AGE and 101 CFU/mL using mPCR-LFB. (B) LoD using DNA of S. Paratyphi A was 104 CFU/mL using mPCR-AGE and 102 CFU/mL using mPCR-LFB. M= 25 bp markers, +ve= positive control, -ve= negative control.
Diagnostics 11 00700 g003
Figure 4. The representative of the mPCR-LFB in line-format.
Figure 4. The representative of the mPCR-LFB in line-format.
Diagnostics 11 00700 g004
Table 1. Primers used in the study.
Table 1. Primers used in the study.
PrimerPrimer Sequence5′-LabelTarget Gene (Accession Number)Target BacteriumAmplicon Size (bp)
FITC_
stgAF
TGATGGCACCGTTCACTTCCTTGFITCstgA
(AL627280.1)
S. Typhi70
Biotin_
stgAR
ATCAGCGGTTTGTGGCGTAACBiotin
Texas red_
SPAintF
CGAACCTGGCAACATACCATTAGATTexas redIntergenic region between SSPA 1723a and SSPA 1724
(FM200053.1)
S. Paratyphi A93
Biotin_
SPAintR
TGCCTCAAATCATCAGTAATCTCTCBiotin
DNP_
ompCF
GCAGCGTGAGCGGTGAAAACACDNPompC
(NC_006511)
Pan-Salmonella146
Biotin_
ompCR
GTTCTGATCGGCAGTACGTTTAGBiotin
DIG_
IACF
GCAGATATTAGGACAAGTTAAGCAAGDIGhemM
(AF22752)
Non-competitive IAC123
Biotin_
IACR
GTTTCTGTTCTTACCCGTTTCBiotin
Table 2. Summary of the results of mPCR-LFB and mPCR-agarose gel electrophoresis (mPCR-AGE) using genomic DNA extracted from 100 isolates of different bacteria strains.
Table 2. Summary of the results of mPCR-LFB and mPCR-agarose gel electrophoresis (mPCR-AGE) using genomic DNA extracted from 100 isolates of different bacteria strains.
Strains (n = 100)No. of StrainsNo. of Positive Test
mPCR-LFB ResultsmPCR-AGE Results
stgASPAintOmpCstgASPAintOmpC
Salmonella Typhi252502525025
Salmonella Paratyphi A250252502525
Other Salmonella serovars
Salmonella Branderup1001001
Salmonella Choleraesuis1001001
Salmonella Paratyphi B2002002
Salmonella Paratyphi C1001001
Salmonella Typhimurium1001001
Salmonella Walter1001001
Salmonella Farsta1001001
Salmonella Richmond1001001
Salmonella Bordes1001001
Salmonella Bordeaux1001001
Salmonella Ayton1001001
Salmonella Virchow1001001
Salmonella Rissen1001001
Salmonella Idikan1001001
Salmonella Abony1001001
Salmonella Albert1001001
Salmonella Eppendorf1001001
Salmonella Corvallis1001001
Salmonella Poona1001001
Salmonella Heidelberg1001001
Salmonella Emek1001001
Salmonella Kissi1001001
Salmonella Djakarta1001001
Salmonella Bareilly1001001
Other bacterial strains
Acinetobacter baumanii1000000
Citrobacter freundii1000000
E. coli1000000
EHEC1000000
EIEC1000000
EPEC1000000
Klebsiella pneumoniae1000000
Proteus mirabilis1000000
Proteus vulgaris1000000
Pseudomonas aeruginosa1000000
Shigella boydii1000000
Shigella dysenteriae1000000
Shigella flexneri1000000
Shigella sonnei1000000
Vibrio cholerae3000000
Yersinia enterocolotica1000000
TOTAL100252575252575
Sensitivity and specificity: 100%, n = number of strains.
Table 3. Summary of mPCR-LFB and culture method for stool samples collected from food handlers and suspected carriers.
Table 3. Summary of mPCR-LFB and culture method for stool samples collected from food handlers and suspected carriers.
N = 1176
(Stool Samples)
Salmonella Typhi (Percentage Positivity)Salmonella Paratyphi A
Culture method3 (0.3%)1 (0.1%)
mPCR-LFB23 (2.0%)3 (0.3%)
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Amalina, Z.N.; Khalid, M.F.; Rahman, S.F.; Ahmad, M.N.; Ahmad Najib, M.; Ismail, A.; Aziah, I. Nucleic Acid-Based Lateral Flow Biosensor for Salmonella Typhi and Salmonella Paratyphi: A Detection in Stool Samples of Suspected Carriers. Diagnostics 2021, 11, 700. https://doi.org/10.3390/diagnostics11040700

AMA Style

Amalina ZN, Khalid MF, Rahman SF, Ahmad MN, Ahmad Najib M, Ismail A, Aziah I. Nucleic Acid-Based Lateral Flow Biosensor for Salmonella Typhi and Salmonella Paratyphi: A Detection in Stool Samples of Suspected Carriers. Diagnostics. 2021; 11(4):700. https://doi.org/10.3390/diagnostics11040700

Chicago/Turabian Style

Amalina, Zulkiply Nor, Muhammad Fazli Khalid, Sjafri Faizul Rahman, Muhamad Nuramin Ahmad, Mohamad Ahmad Najib, Asma Ismail, and Ismail Aziah. 2021. "Nucleic Acid-Based Lateral Flow Biosensor for Salmonella Typhi and Salmonella Paratyphi: A Detection in Stool Samples of Suspected Carriers" Diagnostics 11, no. 4: 700. https://doi.org/10.3390/diagnostics11040700

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop